ABCELLERA BIOLOGICS INC (ABCL) Stock Cash Flow
NASDAQ:ABCL • CA00288U1066
3.13 USD
-0.03 (-0.95%)
At close: Feb 11, 2026
3.19 USD
+0.06 (+1.92%)
Pre-Market: 2/12/2026, 9:03:19 AM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -171.68M | -162.86M | -146.40M | 158.50M | 153.50M | |||
| Depreciation Amortization | 23.80M | 90.85M | 24.39M | 27.90M | 14.50M | |||
| Income Taxes - Deferred | N/A | N/A | 1.96M | -2.10M | -2.00M | |||
| Change In Working Capital | -9.57M | -25.84M | 13.22M | 29.80M | 41.70M | |||
| Other non cash items | 52.90M | -10.71M | 62.94M | 63.30M | 37.00M | |||
| OPERATING CASH FLOW | -104.55M | -108.56M | -43.88M | 277.40M | 244.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -48.56M | -78.40M | -77.51M | -72.70M | -58.50M | |||
| Other Investing Activity | 96.87M | 199.81M | -143.60M | -280.00M | -273.80M | |||
| INVESTING CASH FLOW | 48.31M | 121.41M | -221.11M | -352.60M | -332.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -300.00K | -1.00M | |||
| Stock Issued/Repurchased | 31.13M | 13.50M | 11.59M | 2.80M | 4.60M | |||
| Other Financing Activity | -17.02M | -729.00K | -1.23M | -4.10M | -7.60M | |||
| FINANCING CASH FLOW | 14.11M | 12.77M | 10.36M | -1.60M | -3.90M | |||
| Exchange Rate Effect | -1.35M | -2.62M | 589.00K | -9.60M | -1.40M | |||
| CHANGE IN CASH | -43.48M | 23.00M | -254.04M | -86.40M | -92.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -104.55M | -108.56M | -43.88M | 277.40M | 244.60M | |||
| Capital Expenditure | -48.56M | -78.40M | -77.51M | -72.70M | -58.50M | |||
| FREE CASH FLOW | -153.11M | -186.95M | -121.38M | 204.70M | 186.10M | |||
All data in USD